Pharmacology · Autonomic Nervous System (Cholinergic, Anticholinergic, Sympathomimetics, Sympatholytics)

A 52-year-old man with hypertension and hypertriglyceridemia is started on a non-selective beta-blocker. After three months, his lipid profile shows worsening triglycerides. Which mechanism explains the adverse effect of non-selective beta-blockers on lipid metabolism?

  • A Unopposed alpha-mediated hepatic lipogenesis
  • B Enhanced HMG-CoA reductase activity
  • C Inhibition of lipoprotein lipase due to blockade of beta-2-mediated peripheral vasodilation
  • D Increased LDL receptor expression
Correct answer: C. Inhibition of lipoprotein lipase due to blockade of beta-2-mediated peripheral vasodilation

Explanation

Non-selective beta-blockers reduce lipoprotein lipase activity by blocking beta-mediated vasodilation in skeletal muscle, impairing triglyceride clearance. They typically raise triglycerides by 20-50 percent and lower HDL. Cardio-selective beta-1 blockers without ISA have less effect, but non-selective agents worsen lipid profiles.

Reference: Katzung's Basic and Clinical Pharmacology, 15th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Autonomic Nervous System (Cholinergic, Anticholinergic, Sympathomimetics, Sympatholytics) MCQs

See all Autonomic Nervous System (Cholinergic, Anticholinergic, Sympathomimetics, Sympatholytics) MCQs →